Subscribe to RSS - home infusion

home infusion

NHIA seeks feedback on outcomes elements


ALEXANDRIA, Va. – The National Home Infusion Association is accepting stakeholder comments on newly revised Definitions for Patient Outcomes Data Elements to be used in the collection of data to assess the safety, effectiveness and efficiency of home and specialty infusion care.

Reporter's notebook: Healthcare reform drives growth


Mention the Affordable Care Act to a roomful of HME providers and you’re likely to hear groans about higher costs for their businesses. Home infusion provider Paul Mastrapa, however, sees it as a growth driver.

NHIA to Boehner: Don’t use ASP for home infusion drugs


WASHINGTON – The National Home Infusion Association has asked House Speaker John Boehner to drop a provision in H.R. 2570 that would change the payment structure for infusion drugs under the Part B DME benefit to an average sales price methodology.

Option Care has ‘new energy, vision’

By Theresa Flaherty, Managing Editor

DEERFIELD, Ill. – Four months after a private equity firm acquired a majority stake in Walgreens Infusion Services, the provider has rebranded as Option Care.

Option Care makes comeback


DEERFIELD, Ill. – Walgreens Infusion Services is now Option Care.

Walgreen entered the home infusion market in 2007 when it acquired Option Care for $850 million.

BioScrip offers exchange


ELMSFORD, N.Y. – BioScrip is offering to exchange up to $200 million of senior notes due in 2021 for an equal amount of its outstanding senior notes due 2021. The notes are in aggregate principal amount of 8.875%.

BioScrip off to ‘slow start’ in 2015


ELMSFORD, N.Y. – Despite another quarter of double-digit growth for its home infusion biz, BioScrip execs last week expressed “disappointment” that first quarter 2015 results weren’t stronger.

BioScrip reports 10.6% growth in home infusion


ELMSFORD, N.Y. – BioScrip reported revenues of $261.7 million for the first quarter of 2015, a 9.4% increase compared to the same period in 2014. It reported a net loss of $15.9 million vs. $25.3 million.

BioScrip views infusion as ‘growth engine’


ELMSFORD, N.Y. – BioScrip saw double-digit growth in its home infusion business in 2014 and it expects that to continue in 2015, says President and CEO Rick Smith.

BioScrip sees growth in home infusion


ELMSFORD, N.Y. – BioScrip on March 2 reported revenues of $253.7 million for the fourth quarter of 2014, a 12.5% increase over the same period in 2013.